+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

ICF International Inc (ICFI) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 60 Pages
  • July 2026
  • Region: Global
  • GlobalData
  • ID: 1292155
ICF International Inc (ICFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ICF International Inc (ICF) is a provider of professional services and technology-based solutions. The company offers management, technology, and policy consulting and implementation services. Its service portfolio includes advisory services, program implementation services, analytics services, digital services and engagement services. The company helps clients conceive, develop, implement, and improve solutions that address complex business, social, technological, natural resource, and public safety issues. It caters to government, and commercial clients in energy, environment, and infrastructure; health, education, and social programs; safety and security. The company operates in the Americas, Africa, Asia-Pacific, and Europe. ICF is headquartered in Reston, Virginia, the US.

ICF International Inc Key Recent Developments

  • Jun 05, 2026: Molly Bargmann Joins ICF as Vice President
  • Apr 15, 2026: ICF Wins Energy Efficiency Contract From Georgia Power
  • Feb 23, 2026: Florida Awards ICF Comprehensive Management Services Contract
  • Feb 19, 2026: Southern California Edison Awards Contract Amendment to ICF for Energy Efficiency

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Ionis Pharmaceuticals Inc - Key Facts
  • Ionis Pharmaceuticals Inc - Key Employees
  • Ionis Pharmaceuticals Inc - Key Employee Biographies
  • Ionis Pharmaceuticals Inc - Major Products and Services
  • Ionis Pharmaceuticals Inc - History
  • Ionis Pharmaceuticals Inc - Company Statement
  • Ionis Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
Section 2 - Company Analysis
  • Company Overview
  • Ionis Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Ionis Pharmaceuticals Inc - Corporate Strategy
  • Ionis Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Ionis Pharmaceuticals Inc - Strengths
  • Ionis Pharmaceuticals Inc - Weaknesses
  • Ionis Pharmaceuticals Inc - Opportunities
  • Ionis Pharmaceuticals Inc - Threats
  • Ionis Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Ionis Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 14, 2026: First participant dosed in Ionis’ Phase I-II ASCEND study
  • Jul 13, 2026: Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
  • Jul 07, 2026: Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment
  • Jun 26, 2026: Ionis grants Recordati rights to zilganersen for Alexander disease
  • Jun 08, 2026: Ionis Appoints Ludwig Hantson, Ph.D. to Board of Directors
  • Jun 04, 2026: Ionis to Present New Analyses From CORE and CORE2 Supporting Olezarsen for Severe Hypertriglyceridemia
  • May 28, 2026: Ionis Partner GSK Reports Bepirovirsen Functional Cure Rates in Chronic Hepatitis B
  • May 14, 2026: Ionis Partner Biogen Reports Phase 2 CELIA Results for Diranersen Showing Tau Reduction and Cognitive Benefit in Early Alzheimer's Disease
  • Apr 29, 2026: Ionis Reports First-Quarter 2026 Financial Results and Program Progress
  • Apr 15, 2026: Ionis to Hold First Quarter 2026 Financial Results Webcast
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Ionis Pharmaceuticals Inc, Key Facts
  • Ionis Pharmaceuticals Inc, Key Employees
  • Ionis Pharmaceuticals Inc, Key Employee Biographies
  • Ionis Pharmaceuticals Inc, Major Products and Services
  • Ionis Pharmaceuticals Inc, History
  • Ionis Pharmaceuticals Inc, Other Locations
  • Ionis Pharmaceuticals Inc, Subsidiaries
  • Ionis Pharmaceuticals Inc, Affiliate
  • Ionis Pharmaceuticals Inc, Key Competitors
  • Ionis Pharmaceuticals Inc, Ratios based on current share price
  • Ionis Pharmaceuticals Inc, Annual Ratios
  • Ionis Pharmaceuticals Inc, Interim Ratios
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Ionis Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ionis Pharmaceuticals Inc, Performance Chart (2021 - 2025)
  • Ionis Pharmaceuticals Inc, Ratio Charts
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026